Stockscreener 앱 받기
74.84
0.13%
0.089
전일 마감가:
$74.75
열려 있는:
$74.78
하루 거래량:
314.72K
Relative Volume:
0.10
시가총액:
$16.70B
수익:
$4.04B
순이익/손실:
$557.10M
주가수익비율:
31.05
EPS:
2.4102
순현금흐름:
$916.70M
1주 성능:
+0.41%
1개월 성능:
-0.17%
6개월 성능:
+15.54%
1년 성능:
+1.46%
1일 변동 폭
$74.77
$74.88
1주일 범위
$74.49
$74.89
52주 변동 폭
$51.90
$75.34
홀로직 Stock (HOLX) Company Profile
명칭
Hologic Inc
전화
(508) 263-2900
주소
250 CAMPUS DRIVE, MARLBOROUGH, MA
HOLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
74.84 | 16.67B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
581.32 | 200.78B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
202.10 | 56.69B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
82.14 | 39.62B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
247.38 | 35.81B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
39.42 | 30.70B | 27.43B | 1.27B | 1.01B | 1.5829 |
홀로직 Stock (HOLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-21 | 다운그레이드 | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-08-18 | 업그레이드 | Argus | Hold → Buy |
| 2025-08-06 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-05-27 | 재확인 | Needham | Hold |
| 2025-03-03 | 다운그레이드 | Argus | Buy → Hold |
| 2025-02-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | 다운그레이드 | Needham | Buy → Hold |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-10 | 개시 | Jefferies | Hold |
| 2024-12-10 | 재확인 | Needham | Buy |
| 2024-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-06-27 | 개시 | Stephens | Overweight |
| 2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-14 | 업그레이드 | Needham | Hold → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-07-20 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-07-20 | 개시 | UBS | Neutral |
| 2022-07-18 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-07-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-11-20 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-05 | 재확인 | Needham | Buy |
| 2020-06-30 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-06-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | 재확인 | Needham | Buy |
| 2020-04-30 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | 재확인 | Needham | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | 재확인 | Needham | Buy |
| 2019-05-02 | 재확인 | Needham | Buy |
| 2019-01-31 | 재확인 | Needham | Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | 개시 | UBS | Neutral |
| 2018-09-13 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
홀로직 주식(HOLX)의 최신 뉴스
Hologic Mammography Market Size to Hit USD 8.82 Billion by 2035 - Precedence Research
Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead? - Zacks Investment Research
Diagnostic Device Market to Reach USD 79.9 Billion by 2030 | - openPR.com
Hologic Trading Near 52-Week High: How Should You Play the Stock? - Finviz
Hologic Inc. stock underperforms Thursday when compared to competitors - MSN
Hologic says 2026 CVR is more challenging with stopped shipment of product - MSN
Key facts: Blackstone's stock down 10.2% in 2025; partners with TPG on Hologic - TradingView — Track All Markets
Agree To Buy Hologic At $70, Earn 1.4% Annualized Using Options - Nasdaq
The Future of Bone Sonometer Market 2032 Industry Forecast - openPR.com
Skin Rejuvenation Devices Market Forecast Report: Strategic - openPR.com
Hologic's GYN Surgical Segment Looks Poised for Long-Term Growth - Yahoo Finance
Spotting Winners: Hologic (NASDAQ:HOLX) And Medical Devices & SuppliesImaging, Diagnostics Stocks In Q3 - Yahoo Finance
Hologic stock (HOLX) after-hours on Dec. 24, 2025: CVR milestone risk, Blackstone–TPG deal spread, and what to watch before the next market open - ts2.tech
Hologic says 2026 CVR is more challenging with stopped shipment of product (HOLX:NASDAQ) - Seeking Alpha
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - sharewise.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Diamond Hill Investment Group, Inc. (Nasdaq – DHIL), Synchronoss Technologies (Nasdaq – SNCR), Forge Global Holdings, Inc. (NYSE – FRGE), Hologic, Inc. (Nasdaq – HOLX) - GlobeNewswire Inc.
HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now? - Yahoo Finance
Is Hologic Inc. stock affected by interest rate hikesWeekly Trade Summary & Long-Term Safe Investment Ideas - Улправда
Hologic, Inc. (HOLX) is attracting investor attention: Here is what you should know - MSN
Why retail investors favor Hologic Inc. stockJuly 2025 Levels & Real-Time Market Sentiment Alerts - Улправда
How sustainable is Hologic Inc. stock dividend payoutEarnings Trend Report & Weekly High Potential Alerts - Улправда
Will Hologic Inc. (HO1) stock sustain uptrend momentumQuarterly Growth Report & Verified Short-Term Plans - Улправда
Is Hologic Inc. stock positioned for digital transformation2025 Fundamental Recap & Low Drawdown Momentum Ideas - Улправда
Can Hologic Inc. stock maintain operating margins2025 Market WrapUp & AI Optimized Trading Strategy Guides - Улправда
Meeting tomorrow's diagnostic demands in today's lab - SelectScience
Why Hologic Inc. stock is recommended by analystsJuly 2025 Closing Moves & Consistent Return Investment Signals - DonanımHaber
Why Hologic Inc. stock is seen as undervaluedMarket Trend Review & Consistent Profit Alerts - DonanımHaber
Will Hologic Inc. stock reach Wall Street targetsEarnings Risk Report & Weekly High Conviction Trade Ideas - DonanımHaber
Can Hologic Inc. stock deliver surprise earnings beat2025 Volume Leaders & Real-Time Volume Surge Alerts - Улправда
Digital Breast Tomosynthesis Equipment Market Set to Boom | - openPR.com
Is Hologic Inc. stock gaining market shareJuly 2025 Big Picture & AI Powered Market Trend Analysis - ulpravda.ru
Market Outlook: Will Hologic Inc. (HO1) stock sustain uptrend momentumMarket Growth Summary & Free Accurate Trade Setup Notifications - moha.gov.vn
Hologic data highlights AI’s role in improving mammography accuracy - DOTmed
Portfolio Shifts: Can Hologic Inc. stock maintain operating marginsTrade Entry Report & Fast Exit and Entry Trade Guides - Улправда
Hologic (HOLX) shareholders have earned a 4.8% return over the last year - Yahoo Finance
Responsive Playbooks and the HOLX Inflection - news.stocktradersdaily.com
Hologic's Genius AI Detection Shows Value by Spotting Missed Cancers - sharewise.com
Hologic (HOLX) insider reports 90 shares withheld for tax obligations - Stock Titan
HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases - Yahoo Finance
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Bacterial Drug Sensitivity Testing Market Future Outlook - openPR.com
Uterine Fibroid Treatment Market Forecast to 2032 Reveals Key - openPR.com
Virtual Biopsy Market Emerging Player Outperforming | GE Healthcare, Hologic, Hitachi - openPR.com
Hologic’s AI mammography tech flags previously missed breast cancers - Investing.com India
Study: AI-Powered Mammography Technology Helps Flag Breast Cancer Cases Initially Interpreted as Negative - Imaging Technology News
Hologic’s AI mammography tech flags previously missed breast cancers By Investing.com - Investing.com Nigeria
Hologic Says AI Mammography Flagged 32% of Missed Cancers in General Study - marketscreener.com
Hologic's AI-Powered Mammography Technology Flagged a Third of B - GuruFocus
Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening ExamsHologic, Inc. - Hologic, Inc. - Investor Relations
Hologic stock hits 52-week high at $75.14 By Investing.com - Investing.com Canada
Hologic stock hits 52-week high at $75.14 - Investing.com
홀로직 (HOLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.02%
0.66%
자본화:
|
볼륨(24시간):